Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma-Reply

Affiliations

¹ Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
² Plastic Surgery, Maastricht University Medical Center, Maastricht, Limburg, the Netherlands.
³ Epidemiology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, the Netherlands.

Comment

Daphne de Jong et al. JAMA Oncol. 2018.

. 2018 Oct 1;4(10):1435.

doi: 10.1001/jamaoncol.2018.2624.

¹ Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
² Plastic Surgery, Maastricht University Medical Center, Maastricht, Limburg, the Netherlands.
³ Epidemiology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, the Netherlands.

No abstract available

Comment on

Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast.
de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D. de Boer M, et al. JAMA Oncol. 2018 Mar 1;4(3):335-341. doi: 10.1001/jamaoncol.2017.4510. JAMA Oncol. 2018. PMID: 29302687 Free PMC article.
Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Young-Afat DA. Young-Afat DA. JAMA Oncol. 2018 Oct 1;4(10):1434-1435. doi: 10.1001/jamaoncol.2018.2619. JAMA Oncol. 2018. PMID: 30054604 No abstract available.
Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Swanson E. Swanson E. JAMA Oncol. 2018 Oct 1;4(10):1434. doi: 10.1001/jamaoncol.2018.2616. JAMA Oncol. 2018. PMID: 30054610 No abstract available.